STEMI Secondary to Coronary Vasospasm: Possible Adverse Event of Methylphenidate in a 21-Year-Old Man with ADHD

Methylphenidate (Ritalin(®)) is an increasingly used medication in the treatment of attention-deficit hyperactivity disorder (ADHD). Cardiovascular adverse effects like vasospasm or myocardial infarction are described as very rare adverse effects. We present the case of a 21-year-old man diagnosed w...

Descripción completa

Detalles Bibliográficos
Autores principales: Baumeister, Timo-Benjamin, Wickenbrock, Ingo, Perings, Christian A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033796/
https://www.ncbi.nlm.nih.gov/pubmed/27747690
http://dx.doi.org/10.1007/s40800-016-0035-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033796/
https://www.ncbi.nlm.nih.gov/pubmed/27747690
http://dx.doi.org/10.1007/s40800-016-0035-7

Ejemplares similares